Large language models trained on vast datasets could speed genomics research, streamline clinical documentation, improve real-time diagnostics, support clinical decision-making,…
March 27 (Reuters) – Swiss drugmaker Novartis said on Friday it will buy California-based biotech company Excellergy in a deal…
When you think of biotech companies, you may think of exciting young players that haven’t yet commercialized a product. Those…
By Kane Wu and Andrew Silver HONG KONG/SHANGHAI, Feb 13 (Reuters) – Global drugmakers are stepping up their search for…
In a market where crypto cycles rise and fall while AI feels inevitable and biotech plays out over decades, YZi…
Merger arbitrage investors — fresh off a boom year for dealmaking — expect no let-up in the trend, with biotechnology…
Halozyme Therapeutics and Catalyst Pharmaceuticals are notching double-digit increases in revenue and EPS. With little debt on their balance sheets,…
Krystal Biotech, Inc. (NASDAQ:KRYS) is one of the best strong buy growth stocks to buy according to hedge funds. On January…
The growth of China’s biotechnology sector has been staggering. Beijing is pumping money into the industry, backing research efforts and…
The biotechnology sector offers investors a high-risk, high-reward opportunity as companies race to bring breakthrough therapies to market. Here are…
